Blocking growth to regenerate nerves

Jamming the epidermal growth factor (EGF) receptor allows severed neurons to regenerate.1 "It's a surprising finding," says Martin Schwab of the University of Zurich, as activation of the EGF receptor is normally associated with proliferation and growth of cells.Previous research that sought to explain why mammalian axons fail to regenerate in the wounded brain or spinal cord found several inhibitory cues that prevent healing. The culprits include proteins associated with myelin and proteoglycan

Written bySusan Brown
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Jamming the epidermal growth factor (EGF) receptor allows severed neurons to regenerate.1 "It's a surprising finding," says Martin Schwab of the University of Zurich, as activation of the EGF receptor is normally associated with proliferation and growth of cells.

Previous research that sought to explain why mammalian axons fail to regenerate in the wounded brain or spinal cord found several inhibitory cues that prevent healing. The culprits include proteins associated with myelin and proteoglycans released by the glial scar that forms after neural injury. In a search for a signal that might override this chemical blockade, a group led by Zhigang He of Children's Hospital in Boston cultured neurons on a myelin substrate.

They screened approximately 400 candidate compounds, looking for those that could promote growth in this hostile environment. When exposed to a subset of the molecules that shared the ability to shut down the EGF receptor, neurons sprouted ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies